Cutler Group LP Arcus Biosciences, Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	BUY	$17.23 - $37.73 $861,500 - $1.89 Million	50,000 Added 4545.45%	51,100 $24,000
Q1 2022 Apr 14, 2022	BUY	$28.92 - $41.83 $31,812 - $46,013	1,100 New	1,100 $7,000
Q3 2020 Oct 27, 2020	SELL	$17.14 - $25.47 $1,714 - $2,547	-100 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$8.78 - $19.28 $877 - $1,928	100 New	100 $0

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.